Company

Koa Shoji Holdings Co.,Ltd.

Headquarters: Yokohama, Japan

Employees: 303

CEO: Mr. Toshiyuki Shuto

JPX: 9273

Market Cap

¥25.52 Billion

JPY as of Jan. 1, 2025

US$162.7 Million

Market Cap History

Koa Shoji Holdings Co.,Ltd. Categories

Japan Healthcare Drug Manufacturers—Specialty & Generic
Japan Healthcare Japan Drug Manufacturers—Specialty & Generic

Koa Shoji Holdings Co.,Ltd. market capitalization over time

Evolution of Koa Shoji Holdings Co.,Ltd. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Koa Shoji Holdings Co.,Ltd.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells APIs/intermediates in Japan. It is also involved in the manufacture and marketing of various injections; OTC drugs, primarily various vitamins; and manufacture and sale of generic drugs. In addition, the company engages in contract manufacturing of pharmaceuticals; and packaging of pharmaceutical products. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.

Stocks & Indices

Koa Shoji Holdings Co.,Ltd. has the following listings and related stock indices.


Stock: JPX: 9273 wb_incandescent

Details

Headquarters:

13-15, Hiyoshi 7-chome

Kohoku-ku

Yokohama, 223-0061

Japan